Lymphomas are often difficult to diagnose when they present without clear tumors or detectable abnormalities on standard tests, leading to delays in treatment. This study highlights two patients in whom a blood test analyzing circulating tumor DNA (ctDNA) detected signs of an aggressive lymphoma months before conventional methods confirmed the diagnosis. By identifying ctDNA in the bloodstream, this non-invasive approach could enable earlier detection and faster treatment, helping to shorten the diagnostic process for patients with unexplained symptoms, although further research is needed to determine how and when this approach should be integrated into clinical practice. (https://jmg.bmj.com/content/early/2026/03/31/jmg-2025-111458)